133 related articles for article (PubMed ID: 6450213)
1. Mechanism of cytotoxicity of 5-fluorouracil: distinction between the irreversible cytotoxic effect of 5-fluorouridine and the reversible cytotoxic effect of 5-fluoro-2'-deoxyuridine on murine lymphoma L5178Y cells in culture.
Kanzawa F; Hoshi A; Kuretani K
J Cancer Res Clin Oncol; 1980; 98(1):85-90. PubMed ID: 6450213
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of the murine lymphoma L5178Y cell line highly resistant to 5-fluorouracil.
Kanzawa F; Hoshi A; Kuretani K
J Pharmacobiodyn; 1980 Aug; 3(8):390-4. PubMed ID: 6451684
[TBL] [Abstract][Full Text] [Related]
3. Differences between 5-fluoro-2'-deoxyuridine and 5-fluorouridine in their cytotoxic effect on growth of murine lymphoma L5178Y cells in in vivo and in vitro systems.
Kanzawa F; Hoshi A; Kuretani K
Eur J Cancer (1965); 1980 Aug; 16(8):1087-92. PubMed ID: 6449368
[No Abstract] [Full Text] [Related]
4. The difference in mechanism of action of 5-fluorouracil and its nucleosides in L5178y cells.
Yoshida M; Hoshi A; Kuretani K
J Pharmacobiodyn; 1980 Aug; 3(8):374-9. PubMed ID: 6451683
[TBL] [Abstract][Full Text] [Related]
5. Irreversible cytotoxic effect of a novel lowly immunosuppressive antitumor fluorouridine derivative, UK-21.
Mori H; Nakayama K; Ishida R; Ito S; Nagai H; Koda A
Anticancer Drugs; 1997 Jun; 8(5):482-8. PubMed ID: 9215612
[TBL] [Abstract][Full Text] [Related]
6. Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection.
Mulkins MA; Heidelberger C
Cancer Res; 1982 Mar; 42(3):956-64. PubMed ID: 6460554
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.
Lang TT; Selner M; Young JD; Cass CE
Mol Pharmacol; 2001 Nov; 60(5):1143-52. PubMed ID: 11641443
[TBL] [Abstract][Full Text] [Related]
8. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
Grant S; Cadman E
Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of alkylesters of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP) against murine lymphoma L5178Y resistant to 5-fluoro-2'-deoxyuridine.
Kanzawa F; Matsushima Y; Ishihara J; Hoshi A; Ohba T; Watanabe K
J Pharmacobiodyn; 1986 Aug; 9(8):688-93. PubMed ID: 2946859
[TBL] [Abstract][Full Text] [Related]
10. Modulation of fluoropyrimidine cytotoxicity by methotrexate or 5-methyltetrahydrofolate in human leukemia cells in vitro.
Mini E; Mazzei T; Coronnello M; Criscuoli L; Gualtieri M; Periti P
Chemioterapia; 1984 Dec; 3(6):343-9. PubMed ID: 6241507
[TBL] [Abstract][Full Text] [Related]
11. Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells.
Link KH; Aigner KR; Peschau K; Warthona M; Schwemmle K; Danenberg PV
Cancer Chemother Pharmacol; 1988; 22(1):58-62. PubMed ID: 2969305
[TBL] [Abstract][Full Text] [Related]
12. 5-fluorouracil and 5-fluoro-2'-deoxyuridine follow different metabolic pathways in the induction of cell lethality in L1210 leukaemia.
Roobol C; De Dobbeleer GB; Bernheim JL
Br J Cancer; 1984 Jun; 49(6):739-44. PubMed ID: 6234011
[TBL] [Abstract][Full Text] [Related]
13. Identification and quantitation of 5-fluorouridine in rat urine after administration of 5-fluorouracil or 5-fluoro-2'-deoxyuridine.
Gelijkens CF; Sandra P; Belpaire F; De Leenheer AP
Drug Metab Dispos; 1980; 8(5):363-6. PubMed ID: 6107236
[TBL] [Abstract][Full Text] [Related]
14. The effects of 5-fluorouridine, 5-fluorodeoxyuridine, and 5-fluorodeoxyuridine monophosphate on rabbit tenon's capsule fibroblasts in vitro.
Smyth RJ; Moore JJ; Shapourifar-Tehrani S; Lee DA
J Ocul Pharmacol; 1991; 7(4):329-38. PubMed ID: 1839739
[TBL] [Abstract][Full Text] [Related]
15. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
Takimoto CH; Tan YY; Cadman EC; Armstrong RD
Biochem Pharmacol; 1987 Oct; 36(19):3243-8. PubMed ID: 2444230
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
Iigo M; Nishikata K; Nakajima Y; Szinai I; Veres Z; Szabolcs A; De Clercq E
Biochem Pharmacol; 1990 Apr; 39(7):1247-53. PubMed ID: 2138895
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of induction of gastrointestinal toxicity in the mouse by 5-fluorouracil, 5-fluorouridine, and 5-fluoro-2'-deoxyuridine.
Houghton JA; Houghton PJ; Wooten RS
Cancer Res; 1979 Jul; 39(7 Pt 1):2406-13. PubMed ID: 156065
[No Abstract] [Full Text] [Related]
18. Fluoropyrimidine treatment of ocular cicatricial disease.
Heath TD; Lopez NG; Lewis GP; Stern WH
Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):940-5. PubMed ID: 2940202
[TBL] [Abstract][Full Text] [Related]
19. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
Glazer RI; Lloyd LS
Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and properties of 5-fluorouracil oligonucleotides.
Koga M; Yasusa T; Yamamoto M; Haba S; Suzuki T; Saeki T; Ozaki S
Nucleic Acids Symp Ser; 1995; (34):27-8. PubMed ID: 8841535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
